CBD and Hemp Oil

State and local policy issues impacting dietary supplements across the country.

State and local policy issues impacting dietary supplements across the country.

A summary of selected literature articles related to dietary supplements from the NIH PubMed database that might be of interest to CHPA member companies.

State and local policy issues impacting dietary supplements across the country.

On Tuesday, CHPA President & CEO Scott Melville spoke at an event on Capitol Hill about H.R. 841, legislation that would provide a pathway for dietary supplements containing CBD to be legally marketed.

State and local policy issues impacting dietary supplements across the country.

This week, Senate Finance Committee Chairman Ron Wyden (D-Ore.), Senator Rand Paul (R-Ky.) and Senator Jeff Merkley (D-Ore.) introduced S. 1698, “legislation to ensure hemp-derived CBD products are regulated by the U.S. Food and Drug Administration (FDA) like other legal products used in dietary supplements, foods and beverages – an action that is essential to protecting consumer safety and treating hemp producers fairly.”

CHPA commends Senators Wyden, Paul, and Merkley for their bipartisan bill which will provide a pathway for CBD to be legally marketed as a dietary supplement.

State and local policy issues impacting dietary supplements across the country.

COVID-19 has taught us a lot about minimizing our risk and focusing on wellness and prevention in our lives. Anita and John dig into what this shift means to the dietary supplements category of the consumer healthcare industry.